ISSN: 2474-9222
Authors: Charlotte Bolding*
This research aims to give insight into to the opinions, experiences, and ideas of stakeholders of the veterinary industry regarding current use and integration of cannabidiol (CBD) into canine veterinary care in the UK. Including identifying and evaluating indications, demand and barriers from the perspective of stakeholders of the industry. Semi-structured interviews were conducted with 3 veterinary surgeons, 2 veterinary physiotherapists and 4 owner participants. Grounded theory was used in combination with thematic analysis to identify trends. Results suggested a positive current use of CBD for canines including first-hand experience by all owners. All experiences were positive with no adverse reactions reported. Identified barriers included stigma, lack of research, and issues with product standardization and dosage. Demand for CBD was high by all owners and interest was indicated by professionals. However, professionals expressed reservations more prevalently with the unknown pharmacokinetics of CBD, whereas owners expressed confidence and lower perceived risk. This research is a preliminary investigation into canine focused veterinary CBD use in the UK. Veterinary consumer opinion is also explored where there is currently little existing.
Keywords: BD; Cannabidiol; Canine; Veterinary Market; Owner Opinion; Veterinary Physiotherapy; Epilepsy; Canine Behavior
